Since stem cells were derived in 1998, scientists have hotly debated the ethicality of human embryonic stem cell research. While some people believe that the disassembly of embryos in order to obtain embryonic stem cells is in violation of the right to life of the embryos, the research of these embryonic stem cells has the potential to result in treatments which may save the lives of millions in years to come. Research concerning human embryonic stem cells is thought to hold cures/treatments to Multiple Sclerosis, Diabetes, Parkinson’s Disease, Alzheimer’s Disease, cancer and birth defects. Through the use of stem cells, organ transplants will be at a much lower risk of rejection, as the organs will be grown from the patient 's own DNA ("Benefits
…show more content…
Fortunately, private funding continues to be available. The aforementioned research on developing stem cells into cancer killing cells was funded privately by the National Institutes of Health and the American Society of Hematology ("Embryonic Stem Cell” 4). These same researchers were limited to using two of the federally approved embryonic stem cell lines, which heavily limited their research. If future advancements for the treatment of cancer in humans were to be made, then new embryonic stem cell lines would need to be developed. Since 2005, when this research took place, many things have changed in our government’s policies, including President Obama 's decision in 2009 to reverse the 2001 executive order to stop federal funding of human embryonic stem cell research ("Timeline of Major" 1). In recent years even more progress has been made such as the FDA allowing stems cells to be transplanted into legally blind people, which lead to an increase in their sight and allowed the FDA to determine that the transplant of these types of stem cells is safe in the
Fortunately, private funding continues to be available. The aforementioned research on developing stem cells into cancer killing cells was funded privately by the National Institutes of Health and the American Society of Hematology ("Embryonic Stem Cell” 4). These same researchers were limited to using two of the federally approved embryonic stem cell lines, which heavily limited their research. If future advancements for the treatment of cancer in humans were to be made, then new embryonic stem cell lines would need to be developed. Since 2005, when this research took place, many things have changed in our government’s policies, including President Obama 's decision in 2009 to reverse the 2001 executive order to stop federal funding of human embryonic stem cell research ("Timeline of Major" 1). In recent years even more progress has been made such as the FDA allowing stems cells to be transplanted into legally blind people, which lead to an increase in their sight and allowed the FDA to determine that the transplant of these types of stem cells is safe in the